93 related articles for article (PubMed ID: 7846304)
1. The relevance of hepatic peroxisome proliferation in rats to assessment of human carcinogenic risk for pharmaceuticals.
Kluwe WM
Regul Toxicol Pharmacol; 1994 Oct; 20(2):170-86. PubMed ID: 7846304
[TBL] [Abstract][Full Text] [Related]
2. [Proliferation of peroxisomes and the hepatocarcinogenic process].
Palut D
Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
[TBL] [Abstract][Full Text] [Related]
3. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
4. Rodent carcinogenicity of peroxisome proliferators and issues on human relevance.
Lai DY
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004 May; 22(1):37-55. PubMed ID: 15845221
[TBL] [Abstract][Full Text] [Related]
5. Hepatic peroxisome proliferation in rodents and its significance for humans.
Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ
Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416
[TBL] [Abstract][Full Text] [Related]
6. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
7. [Peroxisome proliferation and possible cancer hazard].
Dybing E; Sanner T
Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1839-41. PubMed ID: 7638833
[TBL] [Abstract][Full Text] [Related]
8. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.
Reddy JK; Lalwai ND
Crit Rev Toxicol; 1983; 12(1):1-58. PubMed ID: 6360536
[TBL] [Abstract][Full Text] [Related]
9. Proliferation of myocardial peroxisomes caused by several agents and conditions.
Zipper J
J Mol Cell Cardiol; 1997 Jan; 29(1):149-61. PubMed ID: 9040030
[TBL] [Abstract][Full Text] [Related]
10. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
11. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
Duclos S; Bride J; Ramirez LC; Bournot P
Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
[TBL] [Abstract][Full Text] [Related]
13. Human HepG2 and rat Fao hepatic-derived cell lines show different responses to ciprofibrate, a peroxisome proliferator: analysis by flow cytometry.
Passilly P; Jannin B; Hassell SJ; Latruffe N
Exp Cell Res; 1996 Mar; 223(2):436-42. PubMed ID: 8601421
[TBL] [Abstract][Full Text] [Related]
14. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
15. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator.
Waxman DJ
J Endocrinol; 1996 Sep; 150 Suppl():S129-47. PubMed ID: 8943797
[TBL] [Abstract][Full Text] [Related]
16. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
17. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the induction of hepatic peroxisome proliferation by the herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes.
Richert L; Price S; Chesne C; Maita K; Carmichael N
Toxicol Appl Pharmacol; 1996 Nov; 141(1):35-43. PubMed ID: 8917673
[TBL] [Abstract][Full Text] [Related]
19. The role of inhibition of gap junctional intercellular communication in rodent liver tumor induction by phthalates: review of data on selected phthalates and the potential relevance to man.
McKee RH
Regul Toxicol Pharmacol; 2000 Aug; 32(1):51-5. PubMed ID: 11029268
[TBL] [Abstract][Full Text] [Related]
20. Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis.
Popp JA; Cattley RC; Miller RT; Marsman DS
Prog Clin Biol Res; 1994; 387():193-207. PubMed ID: 7972246
[No Abstract] [Full Text] [Related]
[Next] [New Search]
